4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-26-091078
10% owner acquired 13,834,441 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DEFJ, LLC 10% owner | 2026-08-03 | Conversion | +11,813,859 | 12,113,899 | D: show line 1 in the form | ||
| DEFJ, LLC 10% owner | 2026-08-03 | Conversion | +2,020,582 | 14,134,481 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DEFJ, LLC 10% owner | 2026-08-03 | Conversion · Series A Non-Voting Convertible Preferred Stock | −1,181.39 | 0 | D: show line 3 in the form | ||
| DEFJ, LLC 10% owner | 2026-08-03 | Conversion · Series B Non-Voting Convertible Preferred Stock | −202.06 | 0 | D: show line 4 in the form |
Loading xslF345X06/tm2622262-2_4seq1.xml…